Apolipoprotein A-I increases the activity of lysosomal glycosidases in the liver of mice with BCG-induced tuberculosis inflammation
https://doi.org/10.18699/SSMJ20210605
Abstract
This work shows the ability of apolipoprotein A-I to influence the activity of lysosomal glycosidases in the liver of mice in a model of BCG-induced tuberculous inflammation. The aim of the investigation was to study the activity of lysosomal glycosidases in the liver of mice using a model of BCG-induced tuberculous inflammation after intravenous administration of apolipoprotein A-I. Material and methods. The studies were performed on male CBA mice weighing 20-22 g. Disseminated tuberculous inflammation was modeled by a single intraperitoneal injection of 0.5 mg of BCG vaccine. The activity of lysosomal glycosidases was assessed spectrofluorimetrically by the content of hydrolysis products of the corresponding fluorogenic substrates. Results. Tuberculous inflammation led to a pronounced decrease in the activity of lysosomal glycosidases in the liver. Thus, β-galactosidase was decreased 2.3 times, β-glucosidase – 2.8 times, β-glucuronidase – 2.5 times compared with healthy animals. Intravenous injection of apolipoprotein A-I to animals against the background of BCG infection prevented a significant decrease in the enzymatic activity of glycosidases and these values practically did not differ from the control values. Conclusions. Enzymatic activity of lysosomal glycosidases in the group of mice with intravenous administration of apolipoprotein A-I against the background of BCG infection was 1.5–2 times higher than the corresponding indicators in the group of animals with BCG-infection without administration of apolipoprotein A-I, i.e. without treatment.
About the Authors
L. M. PolyakovRussian Federation
Lev M. Polyakov, doctor of medical sciences, professor
630117, Novosibirsk, Timakov str., 2
R. A. Knyasev
Russian Federation
Roman A. Knyazev, candidate of biological sciences
630117, Novosibirsk, Timakov str., 2
M. V. Kotova
Russian Federation
Mariay V. Kotova
630117, Novosibirsk, Timakov str., 2
G. S. Russkikh
Russian Federation
Galina S. Russkikh
630117, Novosibirsk, Timakov str., 2
E. I. Soloveva
Russian Federation
Elena I. Soloveva
630117, Novosibirsk, Timakov str., 2
A. V. Ryabchenko
Russian Federation
Aleksandr V. Ryabchenko, candidate of biological sciences
630117, Novosibirsk, Timakov str., 2
References
1. Rozenfeld P., Feriozzi S. Contribution of inflammatory pathways to Fabry disease pathogenesis. Mol. Genet. Metab. 2017;122(3):19–27. doi: 10.1016/j.ymgme.2017.09.004
2. Суменкова Д.В., Поляков Л.М., Панин Л.Е. Влияние комплекса изониазида с аполипопротеином А-I на активность ферментов лизосом у мышей с моделью туберкулезного воспаления. Эксперим. и клин. фармакол. 2012;75(11):28–30. Sumenkova D.V., Polyakov L.M., Panin L.E. Influence of isoniazid complex with A-I apolipoprotein on activity of lysosomal enzymes in mice with tuberculous inflammation model. Eksperimental’naya i klinicheskaya farmakologiya = Experimental and Clinical Pharmacology. 2012;75(11):28–30. [In Russian].
3. Chua J., Vergne I., Master S., Deretic V. A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest. Curr. Opin. Microbiol. 2004;7(1):71– 77. doi: 10.1016/j.mib.2003.12.011
4. Hmama Z., Sendide K., Talal A., Garcia R., Dobos K., Reiner N.E. Quantitative analysis of phagolysosome fusion in intact cells: inhibition by mycobacterial lipoarabinomannan and rescue by an 1alpha,25-dihydroxyvitamin D3-phosphoinositide 3-kinase pathway. J. Cell. Sci. 2004;117(Pt. 10):2131–2140. doi: 10.1242/jcs.01072
5. Шкурупий В.А. Туберкулезный гранулематоз. Цитофизиология и адресная терапия. М.: Изд-во РАМН, 2007. 536 с. Shkurupy V.A. Tuberculous granulomatosis. Cytophysiology and address therapy. Moscow, 2007. 536 c. [In Russian].
6. Sumenkova D.V., Polyakov L.M., Panin L.E. Apolipoprotein A-I as a carrier of lipopolysaccharide into rat hepatocytes. Bull. Exp. Biol. Med. 2013;155(6):738– 740. doi: 10.1007/s10517-013-2240-z
7. Созинов В.А., Метелицына И.П., Плотникова Е.К. Влияние микобактерий туберкулеза на активность лизосомальных факторов перитонеальных макрофагов мышей. Пробл. туберкулеза. 1993;5:44–47. Sozinov V.A., Metelitsyna I.P., Plotnikova E.K. Influence of mycobacterium tuberculosis on the activity of lysosomal factors of peritoneal macrophages in mice. Problemy tuberkuleza = Problems of Tuberculosis. 1993;5:44–47. [In Russian].
8. Yin K., Chen W.J., Zhou Z.G., Zhao G.J., Lv Y.C., Ouyang X.P., Yu X.H., Fu Y., Jiang Z.S., Tang C.K. Apolipoprotein A-I inhibits CD40 proinflammatory signaling via ATP-binding cassette transporter A1-mediated modulation of lipid raft in macrophages. J. Atheroscler. Thromb. 2012;19(9):823–836. doi: 10.5551/jat.12823
9. Hyka N., Dayer J.M., Modoux C., Kohno T., Edwards C.K., Roux-Lombard P., Burger D. Apolipoprotein A-I inhibits the production of interleukin-1 beta and tumor necrosis factor-alpha by blocking contact-mediated activation of monocytes by T lymphocytes. Blood. 2001;97(8):2381–2389. doi: 10.1182/blood.v97.8.2381
10. Tada N., Sakamoto T., Kagami A., Mochizuk K., Kurosaka K. Antimicrobial activity of lipoprotein particles containing apolipoprotein Al. Mol. Cell. Biochem. 1993;119(1-2):171–178. doi: 10.1007/BF00926868
Review
For citations:
Polyakov L.M., Knyasev R.A., Kotova M.V., Russkikh G.S., Soloveva E.I., Ryabchenko A.V. Apolipoprotein A-I increases the activity of lysosomal glycosidases in the liver of mice with BCG-induced tuberculosis inflammation. Сибирский научный медицинский журнал. 2021;41(6):51-55. (In Russ.) https://doi.org/10.18699/SSMJ20210605